Records containing: Overactive Bladder Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-09-05A Prospective Randomized Controlled Trial: Comparison of the Transcutaneous Posterior Tibial Nerve Stimulation and Oral Solifenacin Treatments' Effects in Women Between 18-80 Years Old Who Have Overactive Bladder
-
CLINICAL_TRIALS study record update · 2023-08-14A Randomized Controlled Trial Comparing the Efficacy of a Condensed (Twice Weekly) Protocol to the Standard (Once Per Week) Protocol of Percutaneous Tibial Nerve Stimulation (PTNS) in the Treatment of Overactive Bladder Syndrome (OAB)
-
CLINICAL_TRIALS study record update · 2023-03-29Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome
-
CLINICAL_TRIALS study record update · 2023-03-29Mirabegron for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing
-
CLINICAL_TRIALS study record update · 2023-03-28Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes: A Prospective Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-01-19Development of a Flowchart Reflecting the Current Attitude and Approach Towards the Idiopathic Overactive Bladder Treatment in Belgium: A Delphi Study
-
CLINICAL_TRIALS study record update · 2023-01-04A Randomized-controlled Trial Comparing Transcutaneous Tibial Nerve Stimulation (TTNS) Versus Sham Therapy on Short Term Continence Outcomes in Children With the Idiopathic Overactive Bladder Syndrome: the TaPaS Trial Part I
-
CLINICAL_TRIALS study record update · 2022-10-12Translation of a Novel Overactive Bladder 'Fingerprint' Into a Breakthrough Non-invasive Diagnostic Test for Use in a Point of Care Setting
-
CLINICAL_TRIALS study record update · 2022-08-09Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Treatment of Overactive Bladder. Randomized Clinical Trial.
-
CLINICAL_TRIALS study record update · 2022-08-09Virtual Bladder Training for Overactive Bladder Syndrome in Women. Which Symptom Responds Better?
-
CLINICAL_TRIALS study record update · 2022-03-22Comparison and Evaluation of USSQ (Ureteral Stent Symptom Questionnaire）, OABSS (Overactive Bladder Symptom Score), and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J（Double-J) Stents in Patients Who Underwent URL (Ureteroscopic Holmium Laser Lithotripsy）
-
CLINICAL_TRIALS study record update · 2022-02-22Effect of Combined Use of Tolterodine and Continuous Positive Airway Pressure vs Continuous Positive Airway Pressure Only Treatment on Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-02-10Is Less More? Does Decreasing OnabotulinumtoxinA Injection Sites in the Bladder Increase Patient Satisfaction While Maintaining Efficacy?
-
CLINICAL_TRIALS study record update · 2022-01-12Sequencing and Combination of Mirabegron and Transcutaneous Tibial Nerve Stimulation (TTNS) in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial
-
CLINICAL_TRIALS study record update · 2021-12-15Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-12-09The Role of Primary Nocturnal Enuresis in the Etiology of Overactive Bladder Syndrome
-
CLINICAL_TRIALS study record update · 2021-10-26Urology Department, Hualien Tzu Chi Hospital, Hualien, Taiwan
-
CLINICAL_TRIALS study record update · 2021-10-18Effect of Ureteral Stents Length and Location on Related Symptom
-
CLINICAL_TRIALS study record update · 2021-08-10The Therapeutic Effect of Beta-3 Agonist and Anti-muscarinic Agent on Overactive Bladder Among Sjogren's Syndrome Patient
-
CLINICAL_TRIALS study record update · 2021-07-29A Post-510(k) Study of Patients With Overactive Bladder (OAB) Treated With OnabotulinumtoxinA (Botox, Allergan PLC) Using the Repris Bladder Injection System
-
CLINICAL_TRIALS study record update · 2021-03-03Validation of MenHealth Mobile Uroflowmetry Application
-
CLINICAL_TRIALS study record update · 2021-01-27To Explore the Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and Develop Its Urinary Biomarker
-
CLINICAL_TRIALS study record update · 2021-01-26Comparison of Different Treatments for Overactive Bladder Syndrome
-
CLINICAL_TRIALS study record update · 2020-11-06Incobotulinumtoxin Versus Onabotulinumtoxin in the Treatment of Patients With Overactive Bladder Syndrome
-
CLINICAL_TRIALS study record update · 2020-05-29Oral Phenazopyridine Versus Intravesical Lidocaine for Office OnabotulinumtoxinA Analgesia: A Randomized Controlled Trial